| 来源类型 | Discussion paper
|
| 规范类型 | 论文
|
| 来源ID | DP8371
|
| DP8371 Investments in Pharmaceuticals Before and After TRIPS |
| Margaret Kyle; Anita M McGahan
|
| 发表日期 | 2011-05-01
|
| 出版年 | 2011
|
| 语种 | 英语
|
| 摘要 | This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical treatments. The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of patent protection around the world. Since patents also have the potential to reduce access to treatments through higher prices, it is imperative to assess whether wider use of patents has led to off-setting benefits, such as research on diseases that particularly affect the poor. Using variation across countries in the timing of patent laws and the severity of disease, we test the hypothesis that increased patent protection results in greater drug development effort. We find that patent protection in high income countries is associated with increases in research and development (R&D) effort; in other words, patent protection works in high-income countries to induce R&D. However, the introduction of patents in developing countries has not been followed by greater R&D investment in the diseases that are most prevalent there. Our results suggest that alternative mechanisms for inducing R&D may be more appropriate than patents for the "neglected" diseases that are concentrated in low-income countries. |
| 主题 | Industrial Organization
|
| 关键词 | Health
Innovation
Intellectual property
Pharmaceuticals
Trade policy
|
| URL | https://cepr.org/publications/dp8371
|
| 来源智库 | Centre for Economic Policy Research (United Kingdom)
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/537208
|
推荐引用方式
GB/T 7714 |
Margaret Kyle,Anita M McGahan. DP8371 Investments in Pharmaceuticals Before and After TRIPS. 2011.
|
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
